Connect with us

business

Lab-Shopping & Inflated THC: Is Your Product What You Think?

Published

on


Cannabis testing facilities have proposed many issues since industries started; and its questionable how useful they are. A current and growing issue to plague the industry is that producers are lab-shopping between these facilities, to find the ones that give the results they want. What does this mean for you as the buyer?

Third party testing facilities

When it comes to weed markets, there are two circumstances when testing facilities are used, and the rules for the two are different; in fact, one doesn’t have rules at all. This is because the difference is in whether the products come from a legal market or black market. For example, when dealing with a delta-8 product, lab results come from a different testing facility then a weed product from a regulated company.

That’s because delta-8 products aren’t generally regulated by state, although there are some exceptions. If a state regulates them, then this no longer applies. For the majority that do not, or which outwardly illegalized cannabinoid products; then any testing done, isn’t mandated. If a company isn’t mandated to do testing, it means its doing it for your benefit; or rather, your perceived benefit. And it’s not going to use a regulated lab, because its not a regulated company. This often results in the use of bogus third-party testing facilities.

However, that’s the unregulated market. The regulated market has specifications on these matters; laws that companies must follow in order to remain compliant. These companies aren’t telling you they tested the products to make you happy, they’re doing it because they can’t legally sell their products, if they do not. As such, testing facilities in the legal market are also regulated.

Specifics of product labeling
Specifics of product labeling

If you’re thinking that only unregulated markets have issues with third-party testing though, you’re very much mistaken. Not only are plenty of labs happy to flub results for the benefit of a company; but companies are now shopping around for labs, in order to find ones that are willing to give inflated THC results to make the products seem stronger, and therefore, better. Higher THC does not relate to quality, of course; but for many people it’s the thing they’re looking at when buying a product, and these companies know that.

Recent warning for companies

The level of THC in a product has nothing to do with the quality of the product. It doesn’t mean there won’t be heavy metals or pesticides, or that it’s a desired strain, or that the other components like terpenes and flavonoids, will be at the right levels. All it means is that the product has a high level of THC; and for many people, this is the main issue when shopping for weed products.

In a recent MJBizDaily article, this issue was expanded on. In fact, in California, its such a problem that regulators already sent out warnings to labs licensed in the state, to report only accurate results; or face some kind of repercussions, like license retraction. MJBizdaily apparently was able to get a copy of the letter sent to labs on September 14th, by the state’s Department of Cannabis Control’s Lab Division. The letter stipulates that new random onsite testing will soon occur, for products already tested; as a means to ensure the correct results were reported.

As per the letter, “Inaccurately reporting results and falsification of data will result in action against your license, up to and including revocation.” It continued that “It may also lead to recall and/or embargo of the cannabis or cannabis products.” It stipulated that if Department of Cannabis Control (DCC) results don’t match standard lab results, that this could result in a need to relabel products. This possibility could be costly for companies; but at least doesn’t mean license revocation.

According to DCC Director Nicole Elliott in an email to MJBizdaily, “Randomly testing off-the-shelf products will continue to provide consumers with the confidence that the cannabis products they purchase have been tested and those test results are accurate.”

What does lab-shopping mean?

The cannabis world is a highly competitive place, and this means that companies are constantly fighting to be at the top of it. Since its known that many buyers are mainly looking for high THC levels, companies work to accommodate that desire, by offering high-THC products. Even when this means saying the products are higher in THC than they actually are.

Lab shopping implies finding a lab to give desired results
Lab shopping implies finding a lab to give desired results

Companies have been reported to go ‘lab-shopping’ in order to find labs willing to bend rules, and say that the tested material is higher in THC than it actually is. Often a company will send its product to multiple labs, and take the results of the company that offers the highest THC, or most favorable results; whatever that means to them. Companies often then end up partnering with the labs that give the results they like the best.

The idea that this exists at all, is indicative of an industry in which regulators really aren’t able to regulate. Especially as reports go back to 2019, when Leafly covered the story in the first place. At that time, it was reported that an audit in Oregon found 43% of companies were using at least three labs; an indication in and of itself, of lab-shopping.

In an MJBizDaily article from last year, industry officials said that growers and manufacturers are likely to keep up this behavior of shopping around for labs to give inflated THC amounts, in the absence of state-run labs to oversee private operations. As of right now, its not standard for states to operate labs for verification. California’s attempt to fight this is evidenced by the DCC letters, and the plan to retest material onsite to see if results match. However the question looms of how far-reaching this can go. In reality, the DCC is still limited in that it can’t test everything that comes through.

The MJBizDaily article quoted Jill Ellsworth, the CEO of Willow Industries out of Denver, Colorado on the topic. She stated, “On the lab side, inflated potency results that are not accurate are happening everywhere.” She continued that it would be a great idea if states actually audited third-party, private labs; which is what California is essentially attempting to do now. Except California is doing onsite testing, its not setting up its own state-run lab.

Ellsworth thinks consumer safety should outweigh the desire for companies to provide high-THC products; especially in light of the issues related to the introduction of high THC products, and the resulting issues of THC overdoses. In this sense, the issue of higher-THC products in general, is – at least partly – the fault of legal producers; who are all competing to sell the highest THC products.

What doesn’t come up in the articles I’ve read on this topic, is the idea of why the labs do this. Sure, it could be a measure of their own competition between each other, just to get regular business. But often when an illegal deed like this is done, it’s done for payment. The logic answer here is that not only are companies lab-shopping to find a lab that will accommodate their desires for reporting inflated THC levels, but they’re likely paying in some way to get the job done.

Lab results indicate the percentage of THC in a product
Lab results indicate the percentage of THC in a product

Is there a way to end lab-shopping?

We’re now left with a legal industry, which is just as confounding in terms of the illicit industry, about what exactly is in a product. And this despite the fact we’re supposed to have product transparency in the legal market. For as ‘clean’ as it’s advertised to be, in comparison to the super ‘dirty’ black market; the amount of issues coming out indicates this is not true at all. In fact, not only are there issues with things like heavy metals, and pesticides; but the reality is, we can’t trust any lab results we do get.

There are a couple hard realities concerning improvement with lab-shopping. The first is that the general public doesn’t know. No matter how many educational programs, or signs, or warnings are out there; its unlikely that the population at large will truly understand the issue. Which means they’re not going to put effort into picking through products to find the one with more honest lab results.

Secondly, it was the desires of the population at large that drove these actions in the first place. Maybe its not all about THC, but lets be honest, weed has gotten more intense; and a lot of people like that. As long as there is a desire for the products (and there is, or this wouldn’t happen); companies will do what they have to, to provide what people want to buy.

Beyond all this, the ability to police it all, isn’t possible. The legal industry can only attempt to regulate the legal industry; and a huge percentage operates as a black market, which cannot be tamed by regulatory laws. Considering no legal market has gotten this under control yet; its unlikely there’s a real workable answer. Plus, watching all governments’ complete inability to control the cannabinoid and vape markets; indicates its rather powerless at controlling this industry in general.

Conclusion

Lab-shopping is certainly not ideal, but it seems to be prevalent throughout the weed industry. Perhaps the only way it will stop, is when people decide they don’t want those products anymore.

Welcome one and all! Thanks for dropping into Cannadelics.com; we’re here to bring you the best in independent reporting for cannabis, psychedelics, and well beyond. Stop by when you can to keep up with recent happenings; and sign up for the Cannadelics Weekly Newsletter, to always stay within-the-loop.



Source link

Continue Reading

banking

“A big deal”: What the feds’ move to reclassify marijuana means for Colorado cannabis

Published

on

By



Cannabis advocates in Colorado cheered the Biden Administration’s reported move to reclassify marijuana and said the decision likely would reduce businesses’ tax burden significantly.

Industry leaders cautioned that such a move — if finalized — would not resolve some major challenges facing the industry, such as limited access to banking. But they pointed to the symbolic importance of preparations by the U.S. Drug Enforcement Administration to downgrade the substance’s drug classification.

A man pours cannabis into rolling papers as he prepares to roll a joint the Mile High 420 Festival in Civic Center Park in Denver, April 20, 2024. (Photo by Kevin Mohatt/Special to The Denver Post)

Read the rest of this story on DenverPost.com.



Source link

Continue Reading

business

Astronauts to Test Cannabis Growth in Outer Space

Published

on

By


NASA‘s recent collaboration with the International Space Research Consortium to launch a mission testing the cultivation of cannabis in the microgravity of space has stirred a whirlwind of interest and controversy across the globe. This initiative aims to unravel the mysteries of how low-gravity environments affect plant growth, with cannabis serving as the pioneering subject. According to Dr. Alfred Terra, the esteemed lead scientist spearheading the project, the conditions in space present an “unparalleled opportunity” to push the boundaries of our understanding of botany and its applications in medicine and agriculture beyond Earth’s confines.

This ambitious endeavor aims to shed light on the potential for utilizing space-based agriculture to support long-duration space missions and future colonization efforts on other planets. The choice of cannabis as a research subject is particularly intriguing due to its complex biochemical makeup and its increasing use in medicinal therapies on Earth. Insights gained from how cannabis adapts to space’s harsh environment could lead to breakthroughs in growing food and medicinal plants in extraterrestrial colonies.

Despite the scientific excitement surrounding the mission, the announcement has been met with its share of skepticism and criticism. Some members of the scientific community and the general public question the allocation of resources toward cannabis research in space, arguing that more pressing scientific and exploratory questions merit attention aboard the International Space Station (ISS). These critics call for a focus on projects that directly contribute to our understanding of space travel’s impacts on human physiology or further our knowledge of the cosmos.

However, the space agencies involved have been quick to highlight the broader implications of this research. They argue that studying cannabis growth in microgravity could offer invaluable insights into plant biology, stress responses, and the possibility of cultivating a variety of crops in space, which are crucial for the long-term sustainability of space exploration and eventual human settlement on other planetary bodies.

Amidst the debates over the mission’s merits and the speculation spurred by its announcement date—April 1st—lies a deeper curiosity about the future of space exploration and the role of innovative agricultural research in that journey. The timing has led some to question the announcement’s authenticity, pondering whether it could be an elaborate April Fool’s Day jest aimed at sparking discussion or simply a coincidence that has amplified the public’s fascination with the project.

Whether viewed as a bold step into the future of space agriculture or a controversial choice of research focus, the mission symbolizes a growing intersection between space exploration and the quest to understand and utilize biological processes in unprecedented environments. As the launch date approaches and preparations continue, the world watches, eager to see what insights this venture might unfold about cannabis, plant science, and the potential for life beyond Earth.

*** This article is an April Fool’s Day joke ***



Source link

Continue Reading

business

A Hiring Wave on the Horizon

Published

on

By


The U.S. cannabis industry is on the brink of a significant hiring wave in 2024, spurred by a 12% increase in legal sales in 2023, reaching $29 billion. This growth, alongside potential federal reclassification of cannabis, is expected to create up to 100,000 new jobs, particularly in the retail sector, where 93% of companies plan to expand their workforce. The Vangst 2024 Cannabis Salary Guide highlights an industry ready to bounce back from previous economic stagnation, with a strong emphasis on experience, adaptability, and cultural fit in prospective employees.

The cannabis sector is poised for a massive expansion in employment opportunities in 2024, following a year of economic challenges and layoffs. This optimistic forecast comes from Vangst’s latest industry salary guide, which anticipates a hiring boom driven by increased legal cannabis sales and the potential for federal rescheduling. The anticipated move to reclassify cannabis to Schedule III could significantly reduce tax burdens, increase company valuations, and attract more investors, according to Viridian Capital Advisors.

Retail cannabis companies are at the forefront of this hiring surge, with nearly all surveyed indicating plans to bolster their teams in response to growing demand and market expansion. The focus is not just on filling positions but on finding candidates who can navigate the evolving legal and market landscape, prioritize cultural fit, and possess strong communication skills over traditional qualifications.

Salaries in the cannabis industry have also seen an uptick, with top-end wages growing by 4.7%, outpacing the national non-cannabis average. However, the sector still trails behind others in offering comprehensive benefits packages, a gap that affects employee satisfaction and retention. The demand for health insurance and better work-life balance is clear among job seekers in the cannabis space.

Diversity and inclusion are gaining traction within cannabis company hiring practices, with a significant portion of companies implementing strategies to create a more inclusive workforce. The industry’s employment of veterans and individuals with disabilities highlights its diverse nature, but there remains room for improvement.

Why It Matters: This hiring wave marks a pivotal moment for the cannabis industry, signaling a shift towards recovery and growth after a period of stagnation. It underscores the industry’s resilience and its potential to contribute significantly to the economy through job creation and increased sales.

Potential Implications: The anticipated hiring boom in the cannabis industry could lead to wider acceptance and normalization of cannabis use, further influencing policy changes and societal attitudes. Additionally, the focus on diversity and inclusion could set a precedent for other sectors, promoting a more inclusive workforce across industries.

Source: Green Market Report



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media